Stock Events

Stock Events

Aclaris Therapeutics (8AT.MU) Q1 2026 Earnings

26FebConfirmed

Q1 2026

-0.14

-0.13

-0.13

-0.12

Details

Expected EPS

-0.12262838699999999

Actual EPS

-0.1355712

Surprise EPS

-0.01

Surprise Percent

+10.55%

Description

Aclaris Therapeutics (8AT.MU) has reported earnings of -0.1355712 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.